Targeted Osmotic Lysis (TOL) is investigational. It has not been approved by the FDA for any indication. It is not available as a treatment. Content on this page is educational and describes published scientific literature. It does not describe an available treatment, it does not report results in patients. It does not offer access to any therapy.

FixCancers.com
Research home, FixCancer.org

Educational inquiry

Ask a question

You can send a general educational question. This is not enrollment. This site does not assess eligibility. It does not offer or arrange treatment.

Use the topic list so the question stays in bounds. Do not send medical records.

Ask a question by email. This is not enrollment. It is not a clinical intake. The form stores nothing. It opens your own email client addressed to contact@fixcancer.org. You send the message yourself.

Do not include medical records, diagnoses, lab results, or other protected health information. Questions about your own care belong with a licensed physician.

A question about research in Australia is a question only. No registered human TOL trial is listed on ClinicalTrials.gov, including Australia. This is not an application.

A question about U.S. Right to Try is not an eligibility screen. Stage 3 and stage 4 are how doctors describe advanced cancer. They are not a signup form. Read the Right to Try education page.

A question about CORE Medical and Surgical hospital, Tijuana, Mexico, or a Cedars Sinai signing, is a question about what is documented on the public record. It is not an appointment. This site does not claim that CORE currently offers TOL, treats patients with TOL, or is a trial site.

Fallback: contact@fixcancer.org

The address is contact@fixcancer.org. The form opens your own email client. Nothing is stored on this site.